MiniMed Group, Inc. Common Stock (MMED)vsTempus AI, Inc. Class A Common Stock (TEM)
MMED
MiniMed Group, Inc. Common Stock
$11.79
+0.94%
HEALTHCARE · Cap: $3.40B
TEM
Tempus AI, Inc. Class A Common Stock
$53.50
-1.05%
HEALTHCARE · Cap: $9.87B
Smart Verdict
WallStSmart Research — data-driven comparison
MiniMed Group, Inc. Common Stock generates 135% more annual revenue ($2.99B vs $1.27B). MMED leads profitability with a -10.7% profit margin vs -19.3%. MMED earns a higher WallStSmart Score of 38/100 (F).
MMED
Hold38
out of 100
Grade: F
TEM
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for MMED.
Margin of Safety
-71.3%
Fair Value
$31.29
Current Price
$53.50
$22.21 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
15.0% revenue growth
Revenue surging 83.0% year-over-year
Areas to Watch
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Currently unprofitable
Operating margin of -11.0%
Trading at 19.4x book value
0.0% earnings growth
ROE of -89.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : MMED
The strongest argument for MMED centers on Revenue Growth. Revenue growth of 15.0% demonstrates continued momentum.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.
Bear Case : MMED
The primary concerns for MMED are EPS Growth, Return on Equity, Profit Margin.
Bear Case : TEM
The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Key Dynamics to Monitor
MMED profiles as a turnaround stock while TEM is a hypergrowth play — different risk/reward profiles.
TEM is growing revenue faster at 83.0% — sustainability is the question.
MMED generates stronger free cash flow (13M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MMED scores higher overall (38/100 vs 31/100) and 15.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MiniMed Group, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?